Atherosclerosis: A complex disease;L'athérosclérose: Une maladie complexe

Revue Medicale de Liege

Volumn 67, Issue 5-6, 2012, Pages 273-278

  Kulbertus, H ^a   Lancellotti, P ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Atherosclerosis; Genetic variant; Genome wide association studies; Pharmacogenetics

Indexed keywords

ATHEROSCLEROSIS; DIET; EXERCISE; GENETIC VARIABILITY; HABIT; HEREDITY; HUMAN; PHARMACOGENETICS; PHENOTYPE; REVIEW; SMOKING; STRESS;

ANIMALS; ATHEROSCLEROSIS; CAUSALITY; GENE-ENVIRONMENT INTERACTION; GENETIC TECHNIQUES; HUMANS; PHARMACOGENETICS; RISK FACTORS;

EID: 84863666175     PISSN: 0370629X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Galton J. - The genetics of atherosclerosis. Proceedings of the Nutrition Societ, 1987, 46, 337-343.
2. Roy H, Bhardwaj S, Yla-Herttuala S. - Molecular genetics of atherosclerosis. Hum Genet, 2009, 125, 467-491.
3. Goldstein JL, Hobbs HH, Brown, MS. - Familial Hypercholesterolemia. In : Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY. McGraw-Hill. 2001, 2863-2913.
4. Nofer JR, Remaley AT. - Tangier disease : still more questions than answers. Cell Mol Life Sci, 2005, 62, 2150-2160. (Pubitemid 41500535)
5. Merideth MA, Gordon LB, Clauss S, et al. - Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med, 2008, 358, 592-604. (Pubitemid 351214286)
6. Persu A, Vikkula M. - Génétique et maladies cardiovasculaires athéromateuses in «Athérosclérose- Athérothrombose », Kulbertus H et van Mieghem W Eds, TransMed Medical Communications, 2006, 69-84.
7. Persu A, Vikkula M. - Etudes d'association à l'échelle du génome : une révolution dans la génétique de l'athéromatose ? in «Athéroslérose- Athérothrombose», Kulbertus H et van Mieghem W Eds. TransMed Medical Communications, 2008, 50-60.
8. International HapMap Project. http://hapmap.ncbi.nlm.nih.gov.
9. Samami NJ, Erdmann J, Hall AS, et al. - Genomewide association analysis of coronary artery disease. NEJM, 2007, 357, 443-453. (Pubitemid 47204873)
10. O'Donnel Chr,Nabel EG. - Genomics of cardiovascular disease. N Engl J Med, 2011, 365, 2098-2109.
11. Nainggolan L. - New review puts "explosion"of CVD genomics into context. the Heart.org,Nov 30,2011. http://www.theheart.org/article/1322387/ print.do.
12. Do R, Xie C, Zhang X, et al. - The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake : evidence from a case/control and a prospective study. PLoS Med, 2011, 10, e1001106, doi: 10.1371/journal.pmed.1001106.
13. Sayed-Tabatabaei FA, Schut AFC, Hofman A, et al. - A study of gene-environment interaction on the gene for angiotensin converting enzyme : a combined functional and population based approach. J Med Genet, 2004, 41, 99-103. (Pubitemid 38221747)
14. Ye S, Dhillon S, Seear R, et al. - Epistatic interaction between variations in the angiotensin I converting enzyme and angiotensin II type 1 receptor genes in relation to extent of coronary atherosclerosis. Heart, 2003, 89, 1195-1199. (Pubitemid 37164012)
15. Attie AD. - Atherosclerosis modified. Circ Res, 2001, 89, 102-104.
16. Cyrus T, Witzum JL, Rader DJ, et al. - Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo-E deficient mice. J Clin Invest, 1999, 103, 1597-1604.
17. Makowski L, Boord JB, Maeda K, et al. - Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoproteinE against atherosclerosis. Nat Med, 2001, 7, 699-705. (Pubitemid 32588026)
18. Schwartz UI, Ritchie MD, Bradford Y, et al. - Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med, 2008, 358, 9991-1008.
19. Gage BF, Lesko LJ. - Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues. J Thromb Thrombolysis, 2008, 25, 45-51.
20. Ellis KJ, Stouffer GA, McLeod HL, Lee CR. - Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition : US FDA recommendations. Pharmacogenomics, 2009, 10, 1799-1817.
21. Shin J, Johnson JA. - Pharmacogenetics of β-blockers. Pharmacotherapy, 2007, 27, 874-887.
22. SEARCH Collaborative Group, Link E, Parish S, Armitage J, et al. - SLCO1B1 variants and statin-induced myopathy a genomewide study. N Engl J Med, 2008, 359, 789-799.
23. Arnett DK, Baird AE, Barkely RA, et al; (A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group). - Relevance of genetics and genomics for prevention and treatment of cardiovascular disease. Circulation, 2007, 115, 2878-2901. (Pubitemid 46869676)
24. Hamburg MA, Collins FS. - The path to personalized medicine. N Engl J Med, 2010, 363, 301-304.